Johnson & Johnson Innovation has led a $25 million Series A in targeted cancer radiotherapeutic startup Fusion Pharmaceuticals.

Takeda has teamed up with Cognition Kit to trial the use of an Apple Watch app to monitor people with depression.

Aveo inches closer to completing a crucial trial of its main asset tivozanib—almost four years after the FDA turned down the kidney cancer drug.

Just 12 months ago, Incyte was hit with a major trial setback when its JAK inhibition drug for solid tumors flopped a key test. Since then the biotech has been…

Seventh Sense Biosystems picked up an FDA nod for its “push-button” blood collection device, specifically to test the HbA1c levels in patients with diabetes…

Editors at The BMJ have warned that President Trump’s policies could damage biomedical research and regulation around the world.

Immunexpress earned 510(k) clearance for its RNA-based clinical diagnostic that detects sepsis in critically ill patients. The test, which uses whole blood,…

Celiacs could be freed from the gluten-free aisle of the supermarket if a therapeutic approach developed by ImmusanT proves effective in trials.

Argos' cancer vaccine candidate failed a phase 3 futility analysis, wiping 65% off its stock.